Login / Signup

Serum cytokines and bone metabolic markers in patients with rheumatoid arthritis treated with biological disease modifying anti-rheumatic drugs.

Hiroya TamaiNaoshi NishinaJun KikuchiKeisuke IzumiKotaro OtomoKeiko YoshimotoKunihiro YamaokaTsutomu TakeuchiYuko Kaneko
Published in: Clinical rheumatology (2022)
bDMARDs with different modes of action exert different effects on the cytokine and bone metabolic marker levels in patients with RA.
Keyphrases
  • bone mineral density
  • rheumatoid arthritis
  • soft tissue
  • bone loss
  • postmenopausal women
  • ankylosing spondylitis
  • systemic lupus erythematosus
  • interstitial lung disease
  • drug induced